BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 35130955)

  • 1. Emerging roles of inflammation-mediated endothelial-mesenchymal transition in health and disease.
    Yoshimatsu Y; Watabe T
    Inflamm Regen; 2022 Feb; 42(1):9. PubMed ID: 35130955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 is expressed in the subsets of endothelial cells undergoing partial endothelial-mesenchymal transition in tumor microenvironment.
    Takahashi K; Kobayashi M; Katsumata H; Tokizaki S; Anzai T; Ikeda Y; Alcaide DM; Maeda K; Ishihara M; Tahara K; Kubota Y; Itoh F; Park J; Takahashi K; Matsunaga YT; Yoshimatsu Y; Podyma-Inoue KA; Watabe T
    Cancer Sci; 2024 Feb; 115(2):490-506. PubMed ID: 38111334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of TGF-β signals in tumor microenvironment via regulation of the formation and plasticity of vascular system.
    Watabe T; Takahashi K; Pietras K; Yoshimatsu Y
    Semin Cancer Biol; 2023 Jul; 92():130-138. PubMed ID: 37068553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology.
    Derada Troletti C; Fontijn RD; Gowing E; Charabati M; van Het Hof B; Didouh I; van der Pol SMA; Geerts D; Prat A; van Horssen J; Kooij G; de Vries HE
    Cell Death Dis; 2019 Jan; 10(2):45. PubMed ID: 30718504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD.
    Xavier S; Vasko R; Matsumoto K; Zullo JA; Chen R; Maizel J; Chander PN; Goligorsky MS
    J Am Soc Nephrol; 2015 Apr; 26(4):817-29. PubMed ID: 25535303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SUMOylation of Smad2 mediates TGF-β-regulated endothelial-mesenchymal transition.
    Su Q; Chen X; Ling X; Li D; Ren X; Zhao Y; Yang Y; Liu Y; He A; Zhu X; Yang X; Lu W; Wu H; Qi Y
    J Biol Chem; 2023 Oct; 299(10):105244. PubMed ID: 37690680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial-to-Mesenchymal Transition (EndoMT): Roles in Tumorigenesis, Metastatic Extravasation and Therapy Resistance.
    Platel V; Faure S; Corre I; Clere N
    J Oncol; 2019; 2019():8361945. PubMed ID: 31467544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-155 functions as a negative regulator of RhoA signaling in TGF-β-induced endothelial to mesenchymal transition.
    Bijkerk R; de Bruin RG; van Solingen C; Duijs JM; Kobayashi K; van der Veer EP; ten Dijke P; Rabelink TJ; Goumans MJ; van Zonneveld AJ
    Microrna; 2012; 1(1):2-10. PubMed ID: 25048084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Epsins to Inhibit Fibroblast Growth Factor Signaling While Potentiating Transforming Growth Factor-β Signaling Constrains Endothelial-to-Mesenchymal Transition in Atherosclerosis.
    Dong Y; Wang B; Du M; Zhu B; Cui K; Li K; Yuan K; Cowan DB; Bhattacharjee S; Wong S; Shi J; Wang DZ; Chen K; Bischoff J; Linton MF; Chen H
    Circulation; 2023 Feb; 147(8):669-685. PubMed ID: 36591786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial-mesenchymal transition in normal human esophageal endothelial cells cocultured with esophageal adenocarcinoma cells: role of IL-1β and TGF-β2.
    Nie L; Lyros O; Medda R; Jovanovic N; Schmidt JL; Otterson MF; Johnson CP; Behmaram B; Shaker R; Rafiee P
    Am J Physiol Cell Physiol; 2014 Nov; 307(9):C859-77. PubMed ID: 25163519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders.
    Piera-Velazquez S; Li Z; Jimenez SA
    Am J Pathol; 2011 Sep; 179(3):1074-80. PubMed ID: 21763673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1.
    Wermuth PJ; Li Z; Mendoza FA; Jimenez SA
    PLoS One; 2016; 11(9):e0161988. PubMed ID: 27583804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase 9 induces endothelial-mesenchymal transition via Notch activation in human kidney glomerular endothelial cells.
    Zhao Y; Qiao X; Wang L; Tan TK; Zhao H; Zhang Y; Zhang J; Rao P; Cao Q; Wang Y; Wang Y; Wang YM; Lee VW; Alexander SI; Harris DC; Zheng G
    BMC Cell Biol; 2016 Apr; 17(1):21. PubMed ID: 27130612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study.
    Corallo C; Cutolo M; Kahaleh B; Pecetti G; Montella A; Chirico C; Soldano S; Nuti R; Giordano N
    Arthritis Res Ther; 2016 Oct; 18(1):228. PubMed ID: 27716320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial-to-mesenchymal transition: Pathogenesis and therapeutic targets for chronic pulmonary and vascular diseases.
    Lu X; Gong J; Dennery PA; Yao H
    Biochem Pharmacol; 2019 Oct; 168():100-107. PubMed ID: 31251941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycolysis Promotes Angiotensin II-Induced Aortic Remodeling Through Regulating Endothelial-to-Mesenchymal Transition via the Corepressor C-Terminal Binding Protein 1.
    Wang L; Guo S; Cao K; Li Z; Li Z; Song M; Wang C; Chen P; Cui Y; Dai X; Feng D; Fu X; He J; Xu Y
    Hypertension; 2023 Dec; 80(12):2627-2640. PubMed ID: 37795602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial-to-mesenchymal transition in tumour progression and its potential roles in tumour therapy.
    Yin Z; Wang L
    Ann Med; 2023 Dec; 55(1):1058-1069. PubMed ID: 36908260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An
    Krishnamoorthi MK; Thandavarayan RA; Youker KA; Bhimaraj A
    Front Pharmacol; 2022; 13():912660. PubMed ID: 35814231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial-to-Mesenchymal Transition in Human Adipose Tissue Vasculature Alters the Particulate Secretome and Induces Endothelial Dysfunction.
    Haynes BA; Yang LF; Huyck RW; Lehrer EJ; Turner JM; Barabutis N; Correll VL; Mathiesen A; McPheat W; Semmes OJ; Dobrian AD
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2168-2191. PubMed ID: 31434495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-fibrotic effects of synthetic TGF-β1 and Smad oligodeoxynucleotide on kidney fibrosis in vivo and in vitro through inhibition of both epithelial dedifferentiation and endothelial-mesenchymal transitions.
    Gwon MG; An HJ; Kim JY; Kim WH; Gu H; Kim HJ; Leem J; Jung HJ; Park KK
    FASEB J; 2020 Jan; 34(1):333-349. PubMed ID: 31914629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.